The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer

Recently, Dclk1 expression was identified to be an intestinal cancer stem cell specific biomarker in mouse models, implicating a potential role for targeting the DCLK1-postive cancer cells as a treatment for colorectal cancer. Using quantitative methylation specific PCR (qMSP) we here demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vedeld, Hege Marie, Skotheim, Rolf I, Lothe, Ragnhild A, Lind, Guro E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053453/
https://www.ncbi.nlm.nih.gov/pubmed/24384857
http://dx.doi.org/10.4161/epi.27582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053453/
https://www.ncbi.nlm.nih.gov/pubmed/24384857
http://dx.doi.org/10.4161/epi.27582

Ejemplares similares